Kartika W Taroeno-Hariadi, Camelia Herdini, Aulia S Briliant, Henry K Husodoputro, Wigati Dhamiyati, Sagung Rai Indrasari, Setiyani P Lestari, Yulestrina Widyastuti, Herindita Puspitaningtyas, Risa Rahmasari, Innayah Nur Rachmawati, Ibnu Purwanto, Nurhuda H Setyawan, Ericko Ekaputra, Susanna H Hutajulu, Sri R Dwidanarti, Torana Kurniawan, Lidya Meidania, Seize E Yanuarta, Mardiah S Hardianti, Johan Kurnianda
{"title":"癌症管理核心多学科团队会议提高了患者的护理质量和生存率。","authors":"Kartika W Taroeno-Hariadi, Camelia Herdini, Aulia S Briliant, Henry K Husodoputro, Wigati Dhamiyati, Sagung Rai Indrasari, Setiyani P Lestari, Yulestrina Widyastuti, Herindita Puspitaningtyas, Risa Rahmasari, Innayah Nur Rachmawati, Ibnu Purwanto, Nurhuda H Setyawan, Ericko Ekaputra, Susanna H Hutajulu, Sri R Dwidanarti, Torana Kurniawan, Lidya Meidania, Seize E Yanuarta, Mardiah S Hardianti, Johan Kurnianda","doi":"10.1177/11786329231204757","DOIUrl":null,"url":null,"abstract":"<p><p>Nasopharyngeal cancer (NPC) cases are often diagnosed in advanced stages. The complexity of clinical management for advanced-stage NPC requires thorough communication and shared decisions between medical professionals and allied teams. Incorporating a multidisciplinary team meeting (MDTM) for newly diagnosed NPC patients was chosen to facilitate collaboration and communication between physicians. This retrospective study aimed to compare the quality of care, clinical responses and survival between NPC patients treated with and without MDTM. Data on clinical responses, assessment visits, date of progression and death with progression-free survival (PFS), overall survival (OS), and hazard ratio (HR) were collected and analyzed with 95% confidence interval (CI) and significance set as <i>P</i> < .05. There were 87 of 178 NPC patients treated with MDTM. Revisions of diagnosis and stage occurred in 5.7% and 52.9% of cases during the MDTM. More clinical responses were achieved by patients treated with MDTM (69.0%vs 32.0%, <i>P</i> < .00). NPC patients who received MDTM treatment recommendation had a lower risk for progression (median PFS 59.89 months vs 12.68 months; HR 0.267, 95% CI: 0.17-0.40, <i>P</i> < .00) and mortality (median OS was not reached vs 13.44 months; HR 0.134, 95% CI: 0.08-0.24, <i>P</i> < .00) compared to patients without MDTM. Incorporating the MDTM approach into NPC management improves patients' clinical responses and survival.</p>","PeriodicalId":12876,"journal":{"name":"Health Services Insights","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2023-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/24/10.1177_11786329231204757.PMC10578065.pdf","citationCount":"0","resultStr":"{\"title\":\"Multidisciplinary Team Meeting in the Core of Nasopharyngeal Cancer Management Improved Quality of Care and Survival of Patients.\",\"authors\":\"Kartika W Taroeno-Hariadi, Camelia Herdini, Aulia S Briliant, Henry K Husodoputro, Wigati Dhamiyati, Sagung Rai Indrasari, Setiyani P Lestari, Yulestrina Widyastuti, Herindita Puspitaningtyas, Risa Rahmasari, Innayah Nur Rachmawati, Ibnu Purwanto, Nurhuda H Setyawan, Ericko Ekaputra, Susanna H Hutajulu, Sri R Dwidanarti, Torana Kurniawan, Lidya Meidania, Seize E Yanuarta, Mardiah S Hardianti, Johan Kurnianda\",\"doi\":\"10.1177/11786329231204757\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Nasopharyngeal cancer (NPC) cases are often diagnosed in advanced stages. The complexity of clinical management for advanced-stage NPC requires thorough communication and shared decisions between medical professionals and allied teams. Incorporating a multidisciplinary team meeting (MDTM) for newly diagnosed NPC patients was chosen to facilitate collaboration and communication between physicians. This retrospective study aimed to compare the quality of care, clinical responses and survival between NPC patients treated with and without MDTM. Data on clinical responses, assessment visits, date of progression and death with progression-free survival (PFS), overall survival (OS), and hazard ratio (HR) were collected and analyzed with 95% confidence interval (CI) and significance set as <i>P</i> < .05. There were 87 of 178 NPC patients treated with MDTM. Revisions of diagnosis and stage occurred in 5.7% and 52.9% of cases during the MDTM. More clinical responses were achieved by patients treated with MDTM (69.0%vs 32.0%, <i>P</i> < .00). NPC patients who received MDTM treatment recommendation had a lower risk for progression (median PFS 59.89 months vs 12.68 months; HR 0.267, 95% CI: 0.17-0.40, <i>P</i> < .00) and mortality (median OS was not reached vs 13.44 months; HR 0.134, 95% CI: 0.08-0.24, <i>P</i> < .00) compared to patients without MDTM. Incorporating the MDTM approach into NPC management improves patients' clinical responses and survival.</p>\",\"PeriodicalId\":12876,\"journal\":{\"name\":\"Health Services Insights\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2023-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/83/24/10.1177_11786329231204757.PMC10578065.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Services Insights\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/11786329231204757\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Services Insights","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11786329231204757","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
癌症病例通常诊断为晚期。晚期鼻咽癌临床管理的复杂性要求医疗专业人员和联合团队之间进行彻底的沟通和共享决策。选择为新诊断的NPC患者举办多学科团队会议(MDTM),以促进医生之间的合作和沟通。这项回顾性研究旨在比较使用和不使用MDTM治疗的NPC患者的护理质量、临床反应和生存率。收集并分析临床反应、评估访视、无进展生存期(PFS)、总生存期(OS)和危险比(HR)的进展和死亡数据,95%置信区间(CI)和显著性设置为P P P P
Multidisciplinary Team Meeting in the Core of Nasopharyngeal Cancer Management Improved Quality of Care and Survival of Patients.
Nasopharyngeal cancer (NPC) cases are often diagnosed in advanced stages. The complexity of clinical management for advanced-stage NPC requires thorough communication and shared decisions between medical professionals and allied teams. Incorporating a multidisciplinary team meeting (MDTM) for newly diagnosed NPC patients was chosen to facilitate collaboration and communication between physicians. This retrospective study aimed to compare the quality of care, clinical responses and survival between NPC patients treated with and without MDTM. Data on clinical responses, assessment visits, date of progression and death with progression-free survival (PFS), overall survival (OS), and hazard ratio (HR) were collected and analyzed with 95% confidence interval (CI) and significance set as P < .05. There were 87 of 178 NPC patients treated with MDTM. Revisions of diagnosis and stage occurred in 5.7% and 52.9% of cases during the MDTM. More clinical responses were achieved by patients treated with MDTM (69.0%vs 32.0%, P < .00). NPC patients who received MDTM treatment recommendation had a lower risk for progression (median PFS 59.89 months vs 12.68 months; HR 0.267, 95% CI: 0.17-0.40, P < .00) and mortality (median OS was not reached vs 13.44 months; HR 0.134, 95% CI: 0.08-0.24, P < .00) compared to patients without MDTM. Incorporating the MDTM approach into NPC management improves patients' clinical responses and survival.